Serial life sciences and technology executive, founder, and Board Member at Cytyc, Fair Isaac Corporation (FICO), HNC Software, Indevus Pharmaceuticals, Retek, and Saf-T-Med.
Numerous commercial instrumentation successes in DNA sequencing and DNA microarrays at Life Technologies, Applied Biosystems, Agencourt Personal Genomics, and Rosetta Inpharmatics. B.S. and Ph.D., California Institute of Technology and postdoctoral fellowship with Lee Hood, M.D., Ph.D.
Founder and CEO, MediciNova (NASDAQ: MNOV). President and CEO, Tanabe Research Laboratories, USA, U.S. affiliate of Mitsubishi Tanabe Pharma. M.D. and Ph.D., Keio School of Medicine and M.B.A from Massachusetts Institute of Technology.
Software engineering leader. VP, Software Development at Implant Sciences (acquired by L3 Technologies). Principal Software Engineer at Powerwave and ADC Telecommunications. M.S and B.S. in Computer Engineering, Northeastern University.
Former Partner at Hogan Lovells, Clifford Chance, and Chadbourne & Parke. B.E.E., Cooper Union and J.D., Suffolk University. Admitted in Massachusetts, New York, and U.S. Patent and Trademark Office.
Career in sales and marketing spanning 35 years including VP, Sales and Marketing, ALPCO Diagnostics and executive commercial roles at Thermo Fisher Scientific, Brooks Automation, and Millipore.